These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12967402)

  • 1. Prostate cancer (non-metastatic).
    Wilt T
    Clin Evid; 2003 Jun; (9):973-85. PubMed ID: 12967402
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer (non-metastatic).
    Wilt T
    Clin Evid; 2003 Dec; (10):1023-38. PubMed ID: 15555136
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

  • 4. Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?
    Miyamoto H; Messing EM; Chang C
    Nat Clin Pract Oncol; 2005 May; 2(5):236-7. PubMed ID: 16264955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endocrine therapy for localized or locally advanced prostate cancer].
    Fontaine E; Ruffion A; Staerman F
    Prog Urol; 2004 Jun; 14(3):433-6. PubMed ID: 15373195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of early stage prostate cancer: conservative management--delayed therapy.
    Chodak GW
    Important Adv Oncol; 1994; ():241-4. PubMed ID: 8206492
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
    Allen GW; Howard AR; Jarrard DF; Ritter MA
    Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer of the prostate. What treatment, for which patient, in 1986?].
    Boccon-Gibod L
    Ann Urol (Paris); 1986; 20(2):79-81. PubMed ID: 3717903
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
    Madlung A; Simcock M; Ghadjar P
    Cancer; 2011 Aug; 117(15):3532; author reply 3532-3. PubMed ID: 21287542
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who, when, where, and how: salvage prostate cancer with radiotherapy.
    Chien CP; Roach M
    Oncology (Williston Park); 2010 Jul; 24(8):702, 704. PubMed ID: 20718249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgical and medical treatment for localized prostate cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is maximal androgenic blockade necessary in the treatment of prostatic cancer?].
    Matveev BP; Bukharkin BV
    Urologiia; 2003; (6):6-10. PubMed ID: 14708235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reevaluation of MAB therapy and progress of endocrine therapy].
    Klotz L; Payne H; Gillatt D; Keane T; Morris C; Akaza H; Hirao ; Akakura K; Fukagai T
    Gan To Kagaku Ryoho; 2005 May; 32(5):705-28. PubMed ID: 15934164
    [No Abstract]   [Full Text] [Related]  

  • 17. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating prostate cancer, Part V: radiation therapy.
    Harv Mens Health Watch; 2008 Sep; 13(2):1-4. PubMed ID: 18822517
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure after primary radiation or surgery for prostate cancer: differences in response to androgen ablation.
    Swanson GP; Riggs M; Earle J
    J Urol; 2004 Aug; 172(2):525-8. PubMed ID: 15247720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.